Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Shionogi & Co.

Shionogi & Co.
1878 FOUNDED
PUBLIC STATUS
5K-10K EMPLOYEES
4507 STOCK SYMBOL
4 INVESTMENTS
$53.93 SHARE PRICE (As of Friday Closing)
Description

Shionogi & Co Ltd is a specialty and generic drug manufacturing company. The company focuses on the manufacturing and distribution of pharmaceuticals, diagnostic reagents, and medical devices. Shionogi engages in manufacturing, formulation, packaging, and analysis as part of its commercialization research that spans late stage drug discovery through commercial production. The company's research and development strategy utilizes partnership and licensing opportunities with academic constituents and venture companies.

Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Other Industries
Diagnostic Equipment
Other Devices and Supplies
Stock Exchange
TKS
Primary Office
  • 1-8, Doshomachi 3-chome
  • Chuo-ku
  • Osaka, 541-0045
  • Japan

+81 00-0000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Shionogi & Co.’s full profile, request a free trial.

Shionogi & Co. Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$52.10 - $69.03 $16.8B $53.04 $3.61 972K 311M

Shionogi & Co. Financials Summary

In Thousands,
USD
TTM
30-Jun-2019
FY 2019
31-Mar-2019
FY 2018
31-Mar-2018
FY 2017
31-Mar-2017
Enterprise Value 15,032,885 16,937,854 14,605,631 14,258,668
Revenue 3,190,408 3,280,515 3,109,226 3,127,688
EBITDA 1,439,384 1,693,197 1,405,239 1,277,757
Net Income 1,127,780 1,197,396 982,075 774,137
Total Assets 6,993,769 7,023,309 6,694,867 5,994,904
Total Debt 8,341 8,297 268,100 268,803
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Shionogi & Co. Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Shionogi & Co.‘s full profile, request access.

Request full access to PitchBook

Shionogi & Co. Investments & Acquisitions (4)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000 000 07-Dec-2018 000000000 0000 Drug Discovery 0000000 000000
0000 0000000000 31-Oct-2012 000000000 00000000 Distributors/Wholesale
0000000 000000 18-Jul-2011 000000000000000000 00000 Pharmaceuticals
Sciele Pharma 09-Oct-2008 Merger/Acquisition 00.000 Pharmaceuticals 0000 000000000 00.0
To view this company’s complete investment and acquisition history, request access »

Shionogi & Co. Executive Team (3)

Name Title Board
Seat
Contact
Info
Isao Teshirogi Ph.D Chief Executive Officer & President
Kiyoshi Nagata Ph.D Corporate Officer, Executive General Manager, CMC Development Laboratories
Takeshi Shiota Senior Vice President

Shionogi & Co. Board Members (6)

Name Representing Role Since Contact
Info
0000 000000 Shionogi & Co. Board Member 000 0000
000000000 0000000 Shionogi & Co. Board Member 000 0000
0000000 0000 Shionogi & Co. Board Member 000 0000
000000 000000 Shionogi & Co. Chairman 000 0000
000000 000000 Shionogi & Co. Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »